NASDAQ:ACRV | Key Financial Ratios | Acrivon Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-307.99-74.91%-85.65%
2026-03-318.98-71.65%-80.90%
2025-12-317.69-60.06%-69.24%
2025-09-308.75-56.26%-63.57%
2025-06-3010.31-54.20%-60.09%
2025-03-3111.17-47.49%-52.22%
2024-12-3110.55-40.98%-45.57%
2024-09-3012.75-35.86%-39.10%
2024-06-3016.16-29.92%-31.94%
2024-03-3112.4-53.20%-59.38%
2023-12-319.75-43.68%-49.83%
2023-09-3015.54-33.14%-36.24%
2023-06-3021.84-27.99%-30.03%
2023-03-3121.82-21.57%-22.87%
2022-12-3120.27-17.20%-18.28%
2022-09-3012.31-30.30%58.27%
2022-06-3054.20%
2022-03-3153.41%
2021-12-3134.46-15.24%68.22%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-317.69-60.06%-69.24%
2024-12-3110.55-40.98%-45.57%
2023-12-319.75-43.68%-49.83%
2022-12-3120.27-17.20%-18.28%
2021-12-3134.46-15.24%68.22%